AGENUS INC Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
AGENUS INC (AGEN) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$205.85 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$205.85M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$227.98M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$277.86M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$280.87M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | -$205.85M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$227.98M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | -$277.86M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | -$280.87M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$336.31M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | -$322.40M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | -$306.42M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | -$271.80M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$220.84M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | -$190.32M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | -$148.38M 10-K · filed 2026-03-16 | |
| 2023-09-30 | -$115.29M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$76.76M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | -$53.11M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | -$54.90M 10-K · filed 2026-03-16 | |
| 2022-09-30 | -$11.84M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $13.64M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $27.65M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $47.91M 10-K · filed 2025-03-17 | |
| 2021-09-30 | $35.55M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$255.75M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | -$197.95M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | -$211.50M 10-K · filed 2024-03-14 | |
| 2020-09-30 | -$206.32M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$225.96M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | -$202.50M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | -$231.34M 10-K · filed 2023-03-16 | |
| 2019-09-30 | -$204.87M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$161.61M 10-Q · filed 2020-11-09 | -$161.61M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$119.28M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | -$174.54M 10-K · filed 2022-03-01 | -$174.55M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$131.39M 10-Q · filed 2019-11-07 | -$131.39M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$113.09M 10-Q · filed 2019-11-07 | -$113.09M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$113.23M 10-Q · filed 2019-11-07 | -$113.23M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$75.81M 10-K · filed 2021-03-16 | -$75.82M 10-Q · filed 2018-05-10 |
| 2016-12-31 | -$39.13M 10-K · filed 2020-03-16 | -$39.13M 10-K · filed 2019-03-18 |
| 2015-12-31 | $70.73M 10-K · filed 2019-03-18 | |
| 2012-09-30 | $613.60M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $607.80M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |